Kris Venkat

Kris Venkat

Plus aucun poste en cours
79 ans
Health Technology
Consumer Services
Commercial Services

Profil

Kris Venkat was the Chairman and founder of Indus Biotech Pvt Ltd. He held the position of Chairman and CEO at Sundari LLC from 2000 to 2008.
Dr. Venkat also founded Automated Cell, Inc., Morphochem, Inc., IEP GmbH, Provid Pharmaceuticals, Inc., Thar Technologies, Inc., Aescula Pharma GmbH, and Pharmexx India Ltd. He was the Vice Chairman of Transvivo, Inc. and Fabric Genomics, Inc. and the Chairman-Supervisory Board of Accentua Pharma AG and Juelich Enzyme Products GmbH.
Dr. Venkat was also a Director of Imunon, Inc., Eleos, Inc., Genomics USA, Inc., and Strand Life Sciences Pvt Ltd. He worked as a Principal at Merck & Co., Inc. and as a Senior Advisor at TVM Capital Corp.
Dr. Venkat graduated from Rutgers State University of New Jersey and the University of Minnesota with a graduate degree and from the Indian Institute of Technology Bombay with an undergraduate degree.

Anciens postes connus de Kris Venkat

SociétésPosteFin
Président 01/07/2010
Président 05/04/2010
Pharmexx India Ltd.
Président 17/08/2008
Directeur/Membre du Conseil 18/04/2008
Accentua Pharma AG
Président 18/04/2008
Voir l'expérience en détail de Kris Venkat

Formation de Kris Venkat

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

15

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Consumer Services

Consumer Services

Process Industries

Finance

Commercial Services

Health Technology

Health Technology

Aescula Pharma GmbH

Pharmexx India Ltd.

Commercial Services

Technology Services

Health Technology

Technology Services

Accentua Pharma AG

Juelich Enzyme Products GmbH

Consumer Services

  1. Bourse
  2. Insiders
  3. Kris Venkat